文献速递糖尿病肥胖与代谢综合征

超重与HLA、TCF7L2及FTO基因型在成人隐匿性自身免疫糖尿病和2型糖尿病风险中的交互作用

Interaction Between Overweight and Genotypes of HLA, TCF7L2, and FTO in Relation to the Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该研究合并瑞典和挪威两项人群研究,分析超重(BMI≥25 kg/m2)与HLA、TCF7L2-rs7903146、FTO-rs9939609高风险基因型在LADA和2型糖尿病风险中的交互作用。结果显示超重与HLA、TCF7L2、FTO均存在显著交互作用,增加LADA风险;超重与TCF7L2在2型糖尿病中也存在交互作用,但与HLA或FTO无交互。

要点

  • 超重与HLA高风险基因型交互增加LADA风险,交互作用归因比AP为0.29。
  • 超重与TCF7L2、FTO高风险基因型交互亦增加LADA风险,AP分别为0.31和0.38。
  • 超重与TCF7L2在2型糖尿病中存在交互作用(AP 0.26),但与HLA或FTO无交互。

核心结论

  • 超重与HLA高风险基因型交互促进LADA发生,同时也与2型糖尿病相关基因TCF7L2和FTO交互增加LADA风险。
  • 超重与TCF7L2在2型糖尿病中存在显著交互作用,但与HLA或FTO高风险基因型无交互。

研究设计与样本

  • 汇总两项人群研究:瑞典研究纳入LADA 394例、2型糖尿病1290例及匹配对照2656例;挪威前瞻性研究纳入LADA 131例、2型糖尿病1901例,随访886120人年。
  • 分析调整年龄、性别、体力活动和吸烟,采用交互作用归因比(AP)评估超重(BMI≥25 kg/m2)与HLA/TCF7L2/FTO高风险基因型的交互作用。

主要发现

  • 超重合并HLA、TCF7L2、FTO高风险基因型者LADA的合并相对风险分别为7.59(95%CI 5.27-10.93)、2.65(95%CI 1.97-3.56)、2.21(95%CI 1.60-3.07),参照为正常体重且低/中遗传风险者。
  • 超重与HLA、TCF7L2、FTO的交互作用AP分别为0.29(95%CI 0.10-0.47)、0.31(95%CI 0.09-0.52)、0.38(95%CI 0.15-0.61)。
  • 瑞典数据中,超重且DR4纯合者LADA风险最高,RR为26.76(95%CI 15.42-46.43),AP为0.58(95%CI 0.32-0.83)。
  • 超重与TCF7L2在2型糖尿病中交互作用AP为0.26(95%CI 0.19-0.33),与HLA或FTO无交互。

临床怎么用

  • 对于超重个体,尤其携带HLA高风险基因型者,应关注LADA风险,注意识别自身免疫性糖尿病。
  • 超重与TCF7L2交互也增加2型糖尿病风险,提示肥胖与遗传易感性的联合评估有助于风险分层。

局限性

  • 研究基于瑞典和挪威人群,结果外推需谨慎。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated potential interactions between body mass index (BMI) and genotypes of human leukocyte antigen (HLA), TCF7L2-rs7903146, and FTO-rs9939609 in relation to the risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes. METHODS: We pooled data from two population-based studies: (i) a Swedish study with incident cases of LADA [positive for glutamic acid decarboxylase autoantibodies (GADA); n = 394) and type 2 diabetes (negative for GADA; n = 1290) and matched controls without diabetes (n = 2656) and (ii) a prospective Norwegian study that included incident cases of LADA (n = 131) and type 2 diabetes (n = 1901) and 886,120 person-years of follow-up. Analyses were adjusted for age, sex, physical activity, and smoking. Interaction between overweight (BMI ≥ 25 kg/m2) and HLA/TCF7L2/FTO high-risk genotypes was assessed by attributable proportion due to interaction (AP). RESULTS: The combination of overweight and high-risk genotypes of HLA, TCF7L2, and FTO was associated with pooled relative risk (RRpooled) of 7.59 (95% CI, 5.27 to 10.93), 2.65 (95% CI, 1.97 to 3.56), and 2.21 (95% CI, 1.60 to 3.07), respectively, for LADA, compared with normal-weight individuals with low/intermediate genetic risk. There was a significant interaction between overweight and HLA (AP, 0.29; 95% CI, 0.10 to 0.47), TCF7L2 (AP, 0.31; 95% CI, 0.09 to 0.52), and FTO (AP, 0.38; 95% CI, 0.15 to 0.61). The highest risk of LADA was seen in overweight individuals homozygous for the DR4 genotype [RR, 26.76 (95% CI, 15.42 to 46.43); AP, 0.58 (95% CI, 0.32 to 0.83) (Swedish data)]. Overweight and TCF7L2 also significantly interacted in relation to type 2 diabetes (AP, 0.26; 95% CI, 0.19 to 0.33), but no interaction was observed with high-risk genotypes of HLA or FTO. CONCLUSIONS: Overweight interacts with HLA high-risk genotypes but also with genes associated with type 2 diabetes in the promotion of LADA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hjort R, Löfvenborg JE, Ahlqvist E, et al. Interaction Between Overweight and Genotypes of HLA, TCF7L2, and FTO in Relation to the Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes. J Clin Endocrinol Metab. 2019. PMID: 31125083. doi:10.1210/jc.2019-00183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。